212 related articles for article (PubMed ID: 12731458)
21. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
Patsalos PN
Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction.
Sisodiya SM; Sander JW; Patsalos PN
Epilepsy Res; 2002 Feb; 48(3):217-9. PubMed ID: 11904240
[TBL] [Abstract][Full Text] [Related]
23. [Antiepileptic drugs in North America].
Akiyama T; Otsubo H
Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
[TBL] [Abstract][Full Text] [Related]
24. Use of levetiracetam in special populations.
French J
Epilepsia; 2001; 42 Suppl 4():40-3. PubMed ID: 11564125
[TBL] [Abstract][Full Text] [Related]
25. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics and indications of levetiracetam].
Herranz JL; Argumosa A
Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
Ishii Y; Tanaka T
Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
[No Abstract] [Full Text] [Related]
30. [Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties].
Wagner GL; Wilms EB; Vecht ChJ
Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1218-21. PubMed ID: 12132136
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.
Strolin Benedetti M; Whomsley R; Nicolas JM; Young C; Baltes E
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):621-30. PubMed ID: 14530892
[TBL] [Abstract][Full Text] [Related]
32. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
[TBL] [Abstract][Full Text] [Related]
33. Levetiracetam.
Carreno M
Drugs Today (Barc); 2007 Nov; 43(11):769-94. PubMed ID: 18174964
[TBL] [Abstract][Full Text] [Related]
34. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
35. [Levetiracetam].
Salas-Puig J; Calleja S
Neurologia; 2001 Nov; 16(9):427-32. PubMed ID: 11742623
[TBL] [Abstract][Full Text] [Related]
36. Newer therapies in the drug treatment of epilepsy.
McAuley JW; Biederman TS; Smith JC; Moore JL
Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240
[TBL] [Abstract][Full Text] [Related]
37. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
[TBL] [Abstract][Full Text] [Related]
38. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.
Leppik IE
J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
